Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study (Q44370005)

2 December 2017

title

Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study (English)

1 reference

acute myocardial infarction

2 December 2017

0 references

1 reference

3

Harvey D White

1 reference

2 December 2017

2

John K French

1 reference

2 December 2017

Barbara F Williams

1

1 reference

2 December 2017

HERO-2 consent substudy investigators

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

361

1 reference

2 December 2017

issue

9361

1 reference

2 December 2017

page(s)

918-922

1 reference

Very early thrombolytic therapy in suspected acute myocardial infarction. The Thrombolysis Early in Acute Heart Attack Trial Study Group

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Are we promoting true informed consent in cardiovascular clinical trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Is informed consent to clinical trials an "upside selective" process in acute coronary syndromes?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Obtaining informed consent to neonatal randomised controlled trials: interviews with parents and clinicians in the Euricon study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

The impact of disease severity on the informed consent process in clinical research.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Informed consent in European multicentre randomised clinical trials--are patients really informed?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Patients' experiences of intervention trials on the treatment of myocardial infarction: is it time to adjust the informed consent procedure to the patient's capacity?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Defining patient competence for medical decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

A new readability yardstick.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912773-0

7 January 2021

10.1016/S0140-6736(03)12773-0

Identifiers

DOI

1 reference

2 December 2017

1 reference